MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlson, B. X.
Right arrow Articles by Olsen, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlson, B. X.
Right arrow Articles by Olsen, R. W.

Vol. 57, Issue 3, 474-484, March 2000

A Single Glycine Residue at the Entrance to the First Membrane-Spanning Domain of the gamma -Aminobutyric Acid Type A Receptor beta 2 Subunit Affects Allosteric Sensitivity to GABA and Anesthetics

Berit X. Carlson, A. Christine Engblom, Uffe Kristiansen, Arne Schousboe, and Richard W. Olsen

Department of Pharmacology, The Royal Danish School of Pharmacy, Copenhagen, Denmark (B.X.C., A.C.E., U.K., A.S.); and Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California (R.W.O)

Site-directed mutagenesis of the gamma -aminobutyric acid type A (GABAA) receptor beta 2 subunit has demonstrated that conversion of a conserved glycine residue located at the entrance to the first transmembrane domain into the homologous rho 1 residue phenylalanine alters the modulating effects of four different i.v. anesthetics: pentobarbital, alphaxalone, etomidate, and propofol. Using the baculovirus expression system in Spodoptera frugiperda 9 cells, anesthetic-induced enhancement of [3H]muscimol and [3H]flunitrazepam binding in receptors containing the beta 2(G219F) point mutation displayed a significantly reduced efficacy in modulation by all four i.v. anesthetics tested. Furthermore, GABAA receptors containing the alpha 1(G223F) point mutation also significantly decreased the maximal effect of etomidate- and propofol-induced enhancement of ligand binding. Conversely, the homologous point mutation in rho 1 receptors (F261G) changed the i.v. anesthetic-insensitive receptor to confer anesthetic modulation of [3H]muscimol binding. Consistent with the binding, functional analysis of pentobarbital-enhanced GABA currents recorded with whole-cell patch clamp demonstrated the beta 2(G219F) subunit mutation eliminated the potentiating effect of the anesthetic. Similarly, propofol-enhanced GABA currents were potentiated less in alpha 1beta 2(G219F)gamma 2 receptors than in alpha 1beta 2gamma 2 receptors. Although ligand binding displayed comparable KD values for muscimol among wild-type, alpha 1beta 2gamma 2, and mutant receptors, patch-clamp recordings showed that alpha 1beta 2(G219F)gamma 2 receptors had a significantly more potent response to GABA than did alpha 1beta 2gamma 2 or alpha 1(G223F)beta 2gamma 2. The alpha 1beta 2(G219F)gamma 2 receptors also were more sensitive to direct channel activation by pentobarbital and propofol in the absence of GABA. These results suggest that the first transmembrane glycine residue on the beta 2 subunit may be important for conformational or allosteric interactions of channel gating by both GABA and anesthetics.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
X.-Q. Hu and R. W. Peoples
Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. C. Drafts and J. L. Fisher
Identification of Structures within GABAA Receptor {alpha} Subunits That Regulate the Agonist Action of Pentobarbital
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1094 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Ernst, S. Bruckner, S. Boresch, and W. Sieghart
Comparative Models of GABAA Receptor Extracellular and Transmembrane Domains: Important Insights in Pharmacology and Function
Mol. Pharmacol., November 1, 2005; 68(5): 1291 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. M. Jones-Davis, L. Song, M. J. Gallagher, and R. L. Macdonald
Structural Determinants of Benzodiazepine Allosteric Regulation of GABAA Receptor Currents
J. Neurosci., August 31, 2005; 25(35): 8056 - 8065.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-J. Feng and R. L. Macdonald
Multiple Actions of Propofol on {alpha}{beta}{gamma} and {alpha}{beta}{delta} GABAA Receptors
Mol. Pharmacol., December 1, 2004; 66(6): 1517 - 1524.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Smith, B. Oxley, S. Malpas, G. V. Pillai, and P. B. Simpson
Compounds Exhibiting Selective Efficacy for Different {beta} Subunits of Human Recombinant {gamma}-Aminobutyric AcidA Receptors
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 601 - 609.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Salmi, K. K. Kaisti, L. Metsahonkala, V. Oikonen, S. Aalto, K. Nagren, S. Hinkka, J. Hietala, E. R. Korpi, and H. Scheinin
Sevoflurane and Propofol Increase 11C-Flumazenil Binding to Gamma-Aminobutyric AcidA Receptors in Humans
Anesth. Analg., November 1, 2004; 99(5): 1420 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. H. Streiff, N. O. Juranic, S. I. Macura, D. O. Warner, K. A. Jones, and W. J. Perkins
Saturation Transfer Difference Nuclear Magnetic Resonance Spectroscopy As a Method for Screening Proteins for Anesthetic Binding
Mol. Pharmacol., October 1, 2004; 66(4): 929 - 935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Rusch, H. Zhong, and S. A. Forman
Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation
J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-s. S. Chang, R. Olcese, and R. W. Olsen
A Single M1 Residue in the {beta}2 Subunit Alters Channel Gating of GABAA Receptor in Anesthetic Modulation and Direct Activation
J. Biol. Chem., October 31, 2003; 278(44): 42821 - 42828.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Engblom, B. X. Carlson, R. W. Olsen, A. Schousboe, and U. Kristiansen
Point Mutation in the First Transmembrane Region of the beta 2 Subunit of the gamma -Aminobutyric Acid Type A Receptor Alters Desensitization Kinetics of gamma -Aminobutyric Acid- and Anesthetic-induced Channel Gating
J. Biol. Chem., May 10, 2002; 277(20): 17438 - 17447.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Maruoka, Y. Nagasoe, S. Inoue, Y. Mori, J. Goto, M. Ikeda, and H. Iida
Essential Hydrophilic Carboxyl-terminal Regions Including Cysteine Residues of the Yeast Stretch-activated Calcium-permeable Channel Mid1
J. Biol. Chem., March 29, 2002; 277(14): 11645 - 11652.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Smith, L. Alder, J. Silk, C. Adkins, A. E. Fletcher, T. Scales, J. Kerby, G. Marshall, K. A. Wafford, R. M. McKernan, et al.
Effect of alpha Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant gamma -Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux
Mol. Pharmacol., April 16, 2001; 59(5): 1108 - 1118.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
G. Hapfelmeier, W. Zieglgansberger, R. Haseneder, H. Schneck, and E. Kochs
Nitrous Oxide and Xenon Increase the Efficacy of GABA at Recombinant Mammalian GABAA Receptors
Anesth. Analg., December 1, 2000; 91(6): 1542 - 1549.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics